GUSTAFSEN, CAMILLA,MADSEN, SONDERGAARD PEDER,PEDERSEN, GLERUP SIMON
申请号:
CA3035875
公开号:
CA3035875A1
申请日:
2017.09.20
申请国别(地区):
CA
年份:
2018
代理人:
摘要:
The present disclosure relates to use of heparin analogues as inhibitors of proprotein convertase subtilisin-like/kexin type 9 (PCSK9) for the treatment of lipoprotein metabolism disorders.